3439 Prognostic factors in soft tissue sarcoma patients with lung metastases only receiving first-line chemotherapy. An exploratory, retrospective analysis on fifteen trials of the European Organization for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)

European Journal of Cancer ◽

10.1016/s0959-8049(16)31912-8 ◽

2015 ◽

Vol 51 ◽

pp. S701

Author(s):

L. Lindner ◽

S. Litiere ◽

S. Sleijfer ◽

I. Judson ◽

A. Italiano ◽

...

Keyword(s):

Prognostic Factors ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Retrospective Analysis ◽

Lung Metastases ◽

Bone Sarcoma ◽

First Line ◽

European Organization ◽

Line Chemotherapy

Download Full-text

Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma

International Journal of Cancer ◽

10.1002/ijc.31286 ◽

2018 ◽

Vol 142 (12) ◽

pp. 2610-2620 ◽

Cited By ~ 12

Author(s):

Lars H. Lindner ◽

Saskia Litière ◽

Stefan Sleijfer ◽

Charlotte Benson ◽

Antoine Italiano ◽

...

Keyword(s):

Prognostic Factors ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Retrospective Analysis ◽

Lung Metastases ◽

Bone Sarcoma ◽

First Line ◽

European Organization ◽

Line Chemotherapy

Download Full-text

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study

European Journal of Cancer ◽

10.1016/j.ejca.2013.10.002 ◽

2014 ◽

Vol 50 (2) ◽

pp. 388-396 ◽

Cited By ~ 19

Author(s):

H. Gelderblom ◽

J.Y. Blay ◽

B.M. Seddon ◽

M. Leahy ◽

I. Ray-Coquard ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Bone Sarcoma ◽

First Line ◽

Pharmacogenetic Study ◽

European Organisation ◽

Metastatic Soft Tissue Sarcoma ◽

Line Chemotherapy

Download Full-text

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An EORTC Soft Tissue and Bone Sarcoma Group randomized phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.10037 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 10037-10037 ◽

Cited By ~ 1

Author(s):

H. Gelderblom ◽

J. Blay ◽

B. M. Seddon ◽

M. Leahy ◽

I. L. Ray-Coquard ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Bone Sarcoma ◽

First Line ◽

Randomized Phase Ii ◽

Metastatic Soft Tissue Sarcoma ◽

Line Chemotherapy

Download Full-text

First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study

Annals of Oncology ◽

10.1093/annonc/mdq338 ◽

2011 ◽

Vol 22 (1) ◽

pp. 207-214 ◽

Cited By ~ 104

Author(s):

J.R. Kroep ◽

M. Ouali ◽

H. Gelderblom ◽

A. Le Cesne ◽

T.J.A. Dekker ◽

...

Keyword(s):

Prognostic Factor ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Peripheral Nerve ◽

Bone Sarcoma ◽

Nerve Sheath Tumor ◽

First Line ◽

Peripheral Nerve Sheath Tumor ◽

Nerve Sheath ◽

Line Chemotherapy

Download Full-text

Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy

Gynecologic Oncology ◽

10.1016/j.ygyno.2016.05.016 ◽

2016 ◽

Vol 142 (1) ◽

pp. 95-101 ◽

Cited By ~ 7

Author(s):

I. Ray-Coquard ◽

E. Rizzo ◽

J.Y. Blay ◽

P. Casali ◽

I. Judson ◽

...

Keyword(s):

Clinical Trials ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Bone Sarcoma ◽

Uterine Sarcoma ◽

First Line ◽

Line Chemotherapy

Download Full-text

Faculty Opinions recommendation of Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1355961.827061 ◽

2009 ◽

Author(s):

Florence Duffaud

Keyword(s):

Soft Tissue ◽

Retrospective Analysis ◽

Predictive Factors ◽

Soft Tissue Sarcomas ◽

Bone Sarcoma ◽

Large Series ◽

Adult Patients ◽

First Line ◽

European Organization ◽

Prognostic And Predictive Factors

Download Full-text

Faculty Opinions recommendation of First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9702956.10382054 ◽

2011 ◽

Author(s):

Michelle Scurr

Keyword(s):

Prognostic Factor ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Peripheral Nerve ◽

Bone Sarcoma ◽

Nerve Sheath Tumor ◽

First Line ◽

Peripheral Nerve Sheath Tumor ◽

Nerve Sheath ◽

Line Chemotherapy

Download Full-text

First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histologic soft tissue sarcoma (STS) subtypes and as a prognostic factor for MPNST: An EORTC Soft Tissue and Bone Sarcoma Group (STBSG) study.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.10074 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 10074-10074

Author(s):

J. R. Kroep ◽

M. Ouali ◽

H. Gelderblom ◽

A. Le Cesne ◽

T. J. Dekker ◽

...

Keyword(s):

Prognostic Factor ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Peripheral Nerve ◽

Bone Sarcoma ◽

Nerve Sheath Tumor ◽

First Line ◽

Peripheral Nerve Sheath Tumor ◽

Nerve Sheath ◽

Line Chemotherapy

Download Full-text

1629MO First-line chemotherapy (CT) in advanced well-differentiated/dedifferentiated liposarcoma (WD/DD LPS): An EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1855 ◽

2020 ◽

Vol 31 ◽

pp. S978

Author(s):

S. Stacchiotti ◽

W. Van der Graaf ◽

H. Doms ◽

R. Sanfilippo ◽

S.I. Marreaud ◽

...

Keyword(s):

Soft Tissue ◽

Retrospective Analysis ◽

Bone Sarcoma ◽

Dedifferentiated Liposarcoma ◽

First Line ◽

Well Differentiated ◽

Line Chemotherapy

Download Full-text

Results of a Randomised Phase III Trial (EORTC 62012) of Single Agent Doxorubicin Versus Doxorubicin Plus Ifosfamide as First Line Chemotherapy for Patients with Advanced or Metastatic Soft Tissue Sarcoma: A Survival Study by the Eortc Soft Tissue and Bone Sarcoma Group

Annals of Oncology ◽

10.1016/s0923-7534(20)34351-9 ◽

2012 ◽

Vol 23 ◽

pp. ixe28 ◽

Cited By ~ 7

Author(s):

I. Judson ◽

J. Verweij ◽

H. Gelderblom ◽

J.T. Hartmann ◽

P. Schöffski ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Single Agent ◽

Bone Sarcoma ◽

Phase Iii ◽

First Line ◽

Phase Iii Trial ◽

Survival Study ◽

Metastatic Soft Tissue Sarcoma ◽

Line Chemotherapy

Download Full-text